-->

Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesMay 14, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 13, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 9, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 30, 2019View HTMLDownload DOCDownload PDF
10-QQuarterly report which provides a continuing view of a company's financial positionApr 29, 2019View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
8-KReport of unscheduled material events or corporate eventApr 25, 2019View HTMLDownload DOCDownload PDFDownload XLS
DEFA14AAdditional proxy soliciting materials - definitiveApr 23, 2019View HTMLDownload DOCDownload PDFDownload XLS
DEF 14AOfficial notification to shareholders of matters to be brought to a vote ("Proxy")Apr 23, 2019View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesApr 18, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 15, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 9, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 9, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 9, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 3, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 29, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 29, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 29, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 27, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 26, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 26, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 26, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 26, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 26, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 26, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 26, 2019View HTMLDownload DOCDownload PDF
1-25      26-50      51-67

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information